The U.S. Food and Drug Administration is seeking to simplify the COVID vaccine regimen, potentially moving to annual boosters similar to those given for the flu, the federal agency said in a report today.
An FDA advisory committee is expected to discuss the possibility of a simplified COVID vaccination schedule—which could include one annual dose of an updated booster for many, and two doses for the high-risk—on Thursday, according to a briefing document posted by the federal agency. The committee is also expected to discuss the decision-making process on the composition of future boosters, including a potential new version to be released this fall.
